Omicron case “very mild so far”

Dr. Angelique Coetzee, chairman of the South African Medical Association, said that Omicron’s symptoms have been mild so far and can be treated at home.

“Most of what we present to primary health care professionals are very mild cases, mild to moderate. Therefore, these patients do not need to be hospitalized for now. That means, “said Coetzee, who is also a practitioner. CNN November 30th.

“We are trying to send the message of listening all over the world. We are not saying that this will not be a serious illness. Although it causes a serious illness. If the disease causes mild symptoms in the majority of people, is easy to treat at home and does not require hospitalization, it is the first prize. “

Coetzee was one of the first physicians to suspect a new strain of COVID-19 after seeing seven patients with “very mild” symptoms that differed from those of the predominant Delta variant. Reuters..

During an interview with CNN, Coetzee also advised doctors to test patients with signs of “fatigue,” including one or two days of fatigue. Throat is faint; body aches and pains.

“If we can send that message to the world, it probably means less severity and fewer people will be late for doctors,” she said. “No system can afford it. Neither South Africa nor the United States. No one can afford it.”

Coetzee contracted the vaccinated patient with the Omicron variant, but she admitted that the patient was not “very ill.” But doctors are still “early” to understand the new strains.

The Omicron variant of COVID-19 was detected and published by the National Institute of Infectious Diseases (NICD) in South Africa on November 25.

As of Tuesday, Brazil, Japan and South Korea have reported the first cases of the Omicron variant. As of December 1, Omicron has been reported in 22 countries.

In response to concerns about vaccine breakthroughs, BioNTech founder Ugur Sahin told The Wall Street Journal that variants of Omicron are unlikely to cause serious illness in vaccinated people.

He also urged individuals in an interview to “speed up the administration of the third booster shot.”

Meanwhile, Moderna’s CEO, St├ęphane Bancel, said: Financial Times It will take two weeks to collect data on how the current vaccine worked against the new mutant strain, and months to redevelop the vaccine to fight the new strain.

“I don’t think there is a world. [the effectiveness] It’s on the same level as Delta … “says Bansel.

Tammy Hung